Phacilitate Leaders World

Sponsors & Exhibitors

apceth Biopharma

apceth's vision is to improve patients’ lives with next generation cell therapies. Our programs aim to bring transformative and curative drugs to the patients.

apceth-201 are genetically modified MSCs which expresses Alpha-1 Antitrypsin for the treatment of GvHD, IBD, COPD and diabetes.

apceth-301 are MSCs that expresses a cocktail of cytokines which locally activates the immune system to eradicate tumor cells. apceth-301 is being developed for solid tumors.

We are also a leader in GMP manufacturing of cell-based therapies offering cutting-edge expertise and capabilities. Our unique and comprehensive quality management system has allowed us to successfully obtained manufacturing licenses for multiple cell therapy products. Our facilities are located in Munich, Germany.

Visit Website
View all Sponsors & Exhibitors
Loading
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK